Rxrx stock forecast.

Company Summary. Recursion Pharmaceuticals Inc. is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data ...Sep 11, 2023 · Recursion Pharmaceuticals (RXRX 7.88%) is a biotech that's riding a hype wave unlike any other. By staking its fame and investors' cash on its artificial intelligence (AI) platform for drug ... (See RXRX stock forecast) To find good ideas for stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy , a newly launched tool that unites all of TipRanks’ equity insights.Created with Sketch. when trading, helping you to optimize your price and have a successful order execution. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4 ... Find the latest ARK Genomic Revolution ETF (ARKG) stock quote, history, news and other vital information to help you with your stock trading and investing.

The 7 analysts offering 1 year price forecasts for RXRX have a max estimate of — and a min estimate of —. Analyst rating Based on 7 analysts giving stock ratings to RXRX in …

Recursion Pharmaceuticals, Inc. Analyst Report: Pfizer Inc. Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales ...

Sep 20, 2022 · Zillow is worth $8.3 billion right now, so if it reaches its 2025 sales estimate and continues to grow thereafter, it should breeze past a $10 billion valuation by 2030. 2. Duolingo: Potential ... You can view all of the due diligence checks on RXRX's stock page. How is RXRX stock valued? You can. use many financial metrics, analyses, models, and charts to gauge RXRX's intrinsic value.Using relative valuations . metrics:RXRX; could be undervalued based on its P/B ratio of 3.35x, relative to Biotechnology industry P/B ratio of . 5.36xDec 1, 2023 · The Xerox Corporation stock price gained 1.29% on the last trading day (Friday, 1st Dec 2023), rising from $13.99 to $14.17. During the last trading day the stock fluctuated 4.56% from a day low at $13.60 to a day high of $14.22. The price has risen in 6 of the last 10 days and is up by 4.34% over the past 2 weeks. NVDA stock has risen 3% in July, outperforming the Nasdaq Index, and has surged 200% this year, ... RXRX). The biotech company’s stock surged over 120% following the announcement, ...

Recursion lost $65.3 million compared to a loss of $56 million in the same period a year ago, and said it had $473.1 million in cash. Jim Halley has no position in any of the stocks mentioned. The ...

Planning a trip can be an exciting but challenging task. From booking accommodations to creating an itinerary, there are countless details to consider. One crucial aspect that should never be overlooked is checking the 7-day weather forecas...

Taken together with their deep financial resources, Eli Lilly is one of the best positioned companies to take advantage of the AI-biotech trend. Because Eli Lilly’s future is built off a very ...4.31%. €8.59M. RXRX | Complete Recursion Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.As the old saying goes, “Forewarned is forearmed.” This sentiment holds true when it comes to weather forecasting as well. One of the primary advantages of a 30-day extended weather forecast is the ability to plan ahead with confidence.Recursion Pharmaceuticals Inc. research and ratings by Barron's. View RXRX revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.Get free stock tools, free stock ratings, free stock charts and calculate the value of stocks to buyNasdaq.com will report pre-market and after hours trades. Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of the following day. After Hours trades will be posted from 4:15 p ...

NSD:RXRX Detailed Stock Analysis, Stock Price Forecast, Analyst Ratings, Financial Analysis, Stock News & Historic Quotes5 analysts have issued 12 month price objectives for Amneal Pharmaceuticals' stock. Their AMRX share price targets range from $3.00 to $7.00. On average, they anticipate the company's share price to reach $4.80 in the next year. This suggests a possible upside of 9.3% from the stock's current price.If you bought Keurig K-Cup coffee pods at any point between June 2016 and August 2022, you might be entitled to some cash from a court settlement.Get the latest Recursion Pharmaceuticals Inc (RXRX) real-time quote, historical performance, charts, and other financial information to help you make more informed …Dec 1, 2023 · Earnings for Recursion Pharmaceuticals are expected to decrease in the coming year, from ($1.67) to ($1.91) per share. Recursion Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 26th, 2024 based off prior year's report dates. Read More. Nov 28, 2023 · The Baudax Bio Inc stock price gained 31.73% on the last trading day (Friday, 24th Nov 2023), rising from $0.0646 to $0.0851. During the last trading day the stock fluctuated 41.83% from a day low at $0.0600 to a day high of $0.0851. The price has fallen in 6 of the last 10 days and is down by -54.02% for this period. Nov 13, 2023 · Future criteria checks 0/6. Recursion Pharmaceuticals's revenue and earnings are forecast to decline at 2.9% and 12.8% per annum respectively. EPS is expected to decline by 9% per annum. Return on equity is forecast to be -471.6% in 3 years.

Find the latest ARK Genomic Revolution ETF (ARKG) stock quote, history, news and other vital information to help you with your stock trading and investing.

12 июл. 2023 г. ... Nvidia just invested millions into Recursion Pharmaceuticals, bolstering AI integration in biotech but also presenting risks for RXRX stock.At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.Discover historical prices for RXRX stock on Yahoo Finance. View daily, weekly or monthly format back to when Recursion Pharmaceuticals, Inc. stock was issued.Recursion Pharmaceuticals uses AI and experimental biology to discover new treatments for diseases. Check out why I'm bullish on RXRX stock.(See RXRX stock forecast) Roblox Corporation ( RBLX ) The AI trend has driven 2023’s bullish market sentiment, but one previously anticipated trend has failed to materialize.Zillow is worth $8.3 billion right now, so if it reaches its 2025 sales estimate and continues to grow thereafter, it should breeze past a $10 billion valuation by 2030. 2. Duolingo: Potential ...Dec 1, 2023 · Based on short-term price targets offered by seven analysts, the average price target for Recursion Pharmaceuticals comes to $15.29. The forecasts range from a low of $9.00 to a high of $33.00 ... On the bottom line, Recursion's net loss per share of $0.38 remained flat compared to the prior-year quarter. The company ended the period with $405.9 million in cash and equivalents, which does ...Find the latest Recursion Pharmaceuticals, Inc. (RXRX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and …Nov 24, 2023 · The Recursion Pharmaceuticals, Inc. stock price gained 1.18% on the last trading day (Friday, 24th Nov 2023), rising from $6.78 to $6.86. During the last trading day the stock fluctuated 5.06% from a day low at $6.71 to a day high of $7.05. The price has risen in 7 of the last 10 days and is up by 31.17% over the past 2 weeks.

Currently, Wall Street analysts expect the stock to reach $16.00 within the next 12 months. Recursion Pharmaceuticals Inc [NASDAQ: RXRX] shares were valued at $6.11 at the most recent close of the market. An investor can expect a potential return of 161.87% based on the average RXRX price forecast.

When planning outdoor activities or making travel arrangements, having access to accurate weather forecasts is crucial. One commonly used tool is the 7 day weather forecast, which provides an outlook for the upcoming week.

Scores. RXRX has an Altman Z-Score of 1.67 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy. Detailed statistics for Recursion Pharmaceuticals, Inc. (RXRX) stock, including valuation metrics, financial numbers, share information and more.Stock Price Forecast. According to 9 stock analysts, the average 12-month stock price forecast for HP Inc. stock is $31.56, which predicts an increase of 8.57%. The lowest target is $23 and the highest is $39. On average, analysts rate HP …If you bought Keurig K-Cup coffee pods at any point between June 2016 and August 2022, you might be entitled to some cash from a court settlement.See the latest Recursion Pharmaceuticals Inc Class A stock price (RXRX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.The company raised guidance for annual organic revenue growth from an earlier forecast of between 5% and 7% to between 6% and 8%. It also raised annual adjusted EPS to be between $3.70 and $3.85 ...Sep 20, 2022 · Zillow is worth $8.3 billion right now, so if it reaches its 2025 sales estimate and continues to grow thereafter, it should breeze past a $10 billion valuation by 2030. 2. Duolingo: Potential ... Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.Recursion Pharmaceuticals Stock Chart and Share Price Forecast, Short-Term "RXRX" Stock Prediction for Next Days and Weeks Walletinvestor.com Recursion Pharmaceuticals Inc (RXRX) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024When it comes to complex biotech stocks like Recursion Pharmaceuticals (RXRX 7.88%), skilled investors are likely to have an outsized advantage in understanding how the future will play out ...Three Fool.com healthcare contributors like Vertex Pharmaceuticals ( VRTX 0.22%), Repligen ( RGEN -2.06%), and Recursion Pharmaceuticals ( RXRX -0.69%). Here's why they believe these three stocks ...Should You Buy or Sell Recursion Pharmaceuticals Stock? Get The Latest RXRX Stock Analysis, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.

RXRX has an Altman Z-Score of 1.55 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy. Detailed statistics for Recursion Pharmaceuticals, Inc. (RXRX) stock, including valuation metrics, financial numbers, share information and more.Find the latest Recursion Pharmaceuticals, Inc. RXRX analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. investment rating ...Find the latest Lexicon Pharmaceuticals, Inc. (LXRX) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term ...Recursion's (RXRX) shares rallied almost 191% over the past three months, owing to artificial intelligence-driven acquisitions and strategic collaborations to advance drug development.Instagram:https://instagram. nyse gildstock terminalchat etfblackrock dividend Average. $15.57. Current Price. $7.39. Options. Overview. Research & Ratings. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume ... stocks under 10dollarchromadex 2 days ago · RXRX has an Altman Z-Score of 1.55 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy. Detailed statistics for Recursion Pharmaceuticals, Inc. (RXRX) stock, including valuation metrics, financial numbers, share information and more. willy watson As of Monday, August 07, Recursion Pharmaceuticals Inc’s RXRX share price has dipped by 11.05%, which has investors questioning if this is right time to buy. Premium ... Whether you decide it’s a good time to buy or sell Recursion Pharmaceuticals Inc’s stock based on its stock price forecast is ultimately up to you.RXRX Quantitative Stock Analysis - Benjamin Graham. November 18, 2023 — 01:00 pm EST. Written by John Reese for Validea ->. Below is Validea's guru fundamental report for RECURSION ...